Covid-19
Convalescent
Plasma

Supporting high quality evaluation of
CCP throughout Europe

Learn more >

Project
description

SUPPORT-E - SUPPORTing high quality
evaluation of Covid-19 convalescent plasma
throughout Europe -
is a research project
supported by the European Commission which
brings together major European Blood
Establishments. Its aim is to support high quality

clinical and scientific evaluation of Covid-19
Convalescent Plasma (CCP), using among other things
the dedicated database created by the European Commission.
The main goal of the project is to help EU countries
in both assessing the efficacy of a new therapeutic
solution to deal with the current Coronavirus crisis and
developing new strategies to face potential future pandemics.

Learn more about Support-e >
Learn more about the CCP Database >

Objectives

I

Support High Quality
CCP donation

II

Support High Quality CCP Evaluation in clinical trials and monitored access use programmes

III

Deliver Recommendations for the collection and use of CCP in EU member states to treat Covid-19

IV

Deliver Recommendations for future outbreaks

V

Ensure EU wide adoptions of recommendations and project legacy

News

European Commission invests €36M to support CCP collection

The European Commission has selected 24 projects that will build new programmes, or expand existing ones, for the collection of plasma from donors recovered from COVID-19. The projects, which will take place in 14 Member States and the UK.
Learn more >

Newsletter n.1 is now avalaible

The first newsletter of Support-e project is now available. You can download it by clicking on the link below.
Learn more >

EU Commission allocates €4m grant for SUPPORT-E

The EU-project on COVID-19 convalescent plasma was selected by the European Commission for funding. It will provide recommendations to tackle COVID-19 and guidance on how to best use convalescent plasma to address the current pandemic and potential future ones, at European level.
Learn more >